Ultragenyx Pharmaceutical Inc. Insider Trading for March 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for March 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2019 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | M | 6.86 | 12,000 | 82,320 | 27,878 | |
| Mar 20 2019 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 70.00 | 14,800 | 1,036,000 | 66,357 | 81.2 K to 66.4 K (-18.24 %) |
| Mar 20 2019 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Buy | M | 6.86 | 12,000 | 82,320 | 81,157 | 69.2 K to 81.2 K (+17.35 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Option Exercise | A | 67.55 | 20,000 | 1,351,000 | 20,000 | |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 67.55 | 607 | 41,003 | 21,711 | 22.3 K to 21.7 K (-2.72 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 6,000 | 0 | 22,318 | 16.3 K to 22.3 K (+36.77 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Option Exercise | A | 67.55 | 23,000 | 1,553,650 | 23,000 | |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Payment of Exercise | F | 67.55 | 701 | 47,353 | 36,986 | 37.7 K to 37 K (-1.86 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Grant | A | 0.00 | 20,000 | 0 | 37,687 | 17.7 K to 37.7 K (+113.08 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Hogenhuis Wladimir | Chief Operating Off ... | Option Exercise | A | 67.55 | 11,000 | 743,050 | 11,000 | |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Hogenhuis Wladimir | Chief Operating Off ... | Grant | A | 0.00 | 5,000 | 0 | 20,000 | 15 K to 20 K (+33.33 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Option Exercise | A | 67.55 | 21,500 | 1,452,325 | 21,500 | |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Payment of Exercise | F | 67.55 | 806 | 54,445 | 89,499 | 90.3 K to 89.5 K (-0.89 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Grant | A | 0.00 | 7,000 | 0 | 90,305 | 83.3 K to 90.3 K (+8.40 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | A | 67.55 | 23,000 | 1,553,650 | 23,000 | |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Payment of Exercise | F | 67.55 | 981 | 66,267 | 69,156 | 70.1 K to 69.2 K (-1.40 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Grant | A | 0.00 | 8,000 | 0 | 70,137 | 62.1 K to 70.1 K (+12.87 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | A | 67.55 | 66,000 | 4,458,300 | 66,000 | |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 67.55 | 2,802 | 189,275 | 467,670 | 470.5 K to 467.7 K (-0.60 %) |
| Mar 04 2019 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Grant | A | 0.00 | 20,000 | 0 | 470,472 | 450.5 K to 470.5 K (+4.44 %) |